Posts

Showing posts from 2022

Mystery hepatitis culprit still unidentified: Timeline of a global ... - Healio

Image
December 27, 2022 5 min read ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe ADDED TO EMAIL ALERTS We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Since April 2022, more than 1,300 children in 37 countries have developed acute severe hepatitis of unknown etiology, with the United States and the United Kingdom accounting for 65% of global cases, according to recent WHO data. The outbreak has predominantly affected children aged younger than 10 years, with patients presenting with symptoms of diarrhea and vomiting, often preceding the development of jaundice, abdominal pain, nausea and malaise; some cases progressed to acute liver failure a

Thomson International Inc. Conducts Voluntary Recall of Red ... - FDA.gov

[unable to retrieve full-text content] Thomson International Inc. Conducts Voluntary Recall of Red ...    FDA.gov

Risk factors in carbapenem resistant gram negative bacteria | IDR - Dove Medical Press

Image
Introduction Carbapenem resistant gram-negative bacteria (CR-GNB), namely, carbapenem-resistant Enterobacteriaceae (CRE) (for example, Klebsiella pneumoniae, Escherichia coli), Acinetobacter baumannii (CRAB) and Pseudomonas aeruginosa (CRPA), is an international and national health issue, because they are emerging causes of healthcare-associated infections that are of great concern to the public health. 1 As a result of high levels of antimicrobial resistance (AMR), these bacteria are difficult to treat and are also associated with high mortality. 2 Importantly, due to mobile genetic elements, they may be able to transmit resistance widely. 3 Over 2.8 million cases and 35,000 deaths per year are reported by the disease control and prevention (CDC) as a result of infections caused by resistant bacteria. 4 From 2005 to 2021, the proportion of carbapenem-resistant Klebsiella pneumoniae (CRKP) in China has increased from 3.0% to 24.4%, and that of CRAB from 39.0% to 72.3%. 5 In

Different Types of Typhoid & its Tests - Metropolis Healthcare

Image
What is Typhoid? Typhoid is a bacterial infection that results in high fever, diarrhoea, and vomiting, among other symptoms. Though rare in developed countries, typhoid fever is still very prevalent in developing countries of Southeast Asia, South America, Africa, and India. It has been estimated that about 20 million people suffer from typhoid fever globally every year. Children are at the most significant risk of getting typhoid infection. What Are The Different Types of Typhoid? There are two typhoid types: typhoid fever and paratyphoid fever. Both of these together are grouped as enteric fever. Typhoid and paratyphoid are systemic infections caused by the ingestion of food or water contaminated by the bacterium Salmonella. Typhoid fever is caused by Salmonella typhi, whereas paratyphoid fever is caused by Salmonella paratyphi. Paratyphoid fever is less prevalent and milder in severity than typhoid fever. Enteric fever is quite contagious. If you are infected, you can discha

Expert consensus on the monitoring and treatment of sepsis ... - Military Medical Research

Image
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–10. Article  Google Scholar  Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200–11. Article  Google Scholar  van der Poll T, van de Veerdonk FL, Scicluna BP, Netea MG. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol. 2017;17(7):407–20. Article  Google Scholar  Venet F, Monneret G. Advances in the understanding and treatment of sepsis-induced immunosuppression. Nat Rev Nephrol. 2018;14(2):121–37. Article